BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas-kidney recipients.
BK virus
allograft failure
kidney transplantation
nephropathy
pancreas transplantation
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
26
08
2023
received:
08
06
2023
accepted:
06
09
2023
medline:
13
11
2023
pubmed:
14
9
2023
entrez:
14
9
2023
Statut:
ppublish
Résumé
BK polyomavirus (BKV) infection is a common complication of kidney transplantation. While BKV has been described in non-kidney transplant recipients, data are limited regarding its epidemiology and outcomes in pancreas transplant recipients. We conducted a retrospective cohort study of adults who underwent pancreas transplantation from 2010-2020. The primary outcome was BKV DNAemia. Secondary outcomes were estimated glomerular filtration rate (eGFR) reduction by 30%, eGFR < 30 mL/min/1.73 m Four hundred and sixty-six patients were analyzed, including 74, 46, and 346 with pancreas transplant alone (PTA), pancreas-after-kidney, or simultaneous pancreas-kidney transplants, respectively. PTA recipients experienced a lower incidence of BKV DNAemia (8.8% vs. 32.9%; p < .001) and shorter duration of DNAemia (median 28.0 vs. 84.5 days). No PTA recipients with BKV DNAemia underwent kidney biopsy or developed endstage kidney disease. Lymphopenia, non-PTA transplantation, and older age were associated with BKV DNAemia, which itself was associated with pancreas allograft failure (adjusted hazard ratio 2.14, 95% confidence interval 1.27-3.60; p = .004). Among PTA recipients, BKV DNAemia was not associated with eGFR reduction or eGFR < 30 mL/min/1.73 m BKV DNAemia was common among PTA recipients, though lower than a comparable group of pancreas-kidney recipients. However, BKV DNAemia was not associated with adverse native kidney outcomes and no PTA recipients developed endstage kidney disease. Conversely, BKV DNAemia was associated with pancreas allograft failure. Further studies are needed to estimate the rate of BKV nephropathy in this population, and further evaluate long-term kidney outcomes.
Sections du résumé
BACKGROUND
BK polyomavirus (BKV) infection is a common complication of kidney transplantation. While BKV has been described in non-kidney transplant recipients, data are limited regarding its epidemiology and outcomes in pancreas transplant recipients.
METHODS
We conducted a retrospective cohort study of adults who underwent pancreas transplantation from 2010-2020. The primary outcome was BKV DNAemia. Secondary outcomes were estimated glomerular filtration rate (eGFR) reduction by 30%, eGFR < 30 mL/min/1.73 m
RESULTS
Four hundred and sixty-six patients were analyzed, including 74, 46, and 346 with pancreas transplant alone (PTA), pancreas-after-kidney, or simultaneous pancreas-kidney transplants, respectively. PTA recipients experienced a lower incidence of BKV DNAemia (8.8% vs. 32.9%; p < .001) and shorter duration of DNAemia (median 28.0 vs. 84.5 days). No PTA recipients with BKV DNAemia underwent kidney biopsy or developed endstage kidney disease. Lymphopenia, non-PTA transplantation, and older age were associated with BKV DNAemia, which itself was associated with pancreas allograft failure (adjusted hazard ratio 2.14, 95% confidence interval 1.27-3.60; p = .004). Among PTA recipients, BKV DNAemia was not associated with eGFR reduction or eGFR < 30 mL/min/1.73 m
CONCLUSIONS
BKV DNAemia was common among PTA recipients, though lower than a comparable group of pancreas-kidney recipients. However, BKV DNAemia was not associated with adverse native kidney outcomes and no PTA recipients developed endstage kidney disease. Conversely, BKV DNAemia was associated with pancreas allograft failure. Further studies are needed to estimate the rate of BKV nephropathy in this population, and further evaluate long-term kidney outcomes.
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15135Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002377
Pays : United States
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Qeska D, Wong RBK, Famure O, et al. Incidence, risk factors, outcomes, and clinical management of BK viremia in the modern era of kidney transplantation. Transpl Infect Dis. 2022;24(6). doi:10.1111/tid.13915
Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9). doi:10.1111/ctr.13528
Yoon S-H, Cho J-H, Jung H-Y, et al. Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients. Transplant Proc. 2015;47(3):660-665. doi:10.1016/j.transproceed.2014.11.051
Manzano Sánchez D, Jimeno García L, Manzano Sánchez D, et al. Renal function impairment in kidney transplantation: importance of early BK virus detection. Transplant Proc. 2019;51(2):350-352. doi:10.1016/j.transproceed.2018.12.016
Viswesh V, Yost SE, Kaplan B. The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review. Transplant Rev. 2015;29(3):175-180. doi:10.1016/j.trre.2015.02.004
Mallavarapu RK, Sanoff SL, Howell DN, Roberts JK. BK virus nephropathy in non-renal solid organ transplant recipients: are we looking hard enough? Clin Transplant. 2021;35(5). doi:10.1111/ctr.14265
Haririan A, Hamze O, Drachenberg CB, Ramos E, Weir MR, Klassen DK. Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. Transplantation. 2003;75(8):1186-1190. doi:10.1097/01.TP.0000061597.09830.49
Kroth LV, Henkin CS, Peres LD, et al. Prevalence of urinary decoy cells and associated risk factors in a Brazilian kidney, pancreas, and kidney-pancreas transplant population. Transplant Proc. 2012;44(8):2394-2396. doi:10.1016/j.transproceed.2012.07.008
Imlay H, Whitaker K, Fisher CE, Limaye AP. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and pancreas-kidney transplant recipients. Transpl Infect Dis. 2018;20(4):e12928. doi:10.1111/tid.12928
Westphal SG, Lyden ER, Langewisch ED, Miles CD. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients. Clin Transplant. 2017;31(8):e13010. doi:10.1111/ctr.13010
Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
OPTN/UNOS Pancreas Transplantation Committee Definition of Pancreas Graft Failure, July 1, 2015. Accessed March 8, 2023. https://optn.transplant.hrsa.gov/media/1572/policynotice_20150701_pancreas.pdf
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi:10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
Meesing A, Razonable RR. Absolute lymphocyte count thresholds: a simple, readily available tool to predict the risk of cytomegalovirus infection after transplantation. Open Forum Infect Dis. 2018;5(10). doi:10.1093/ofid/ofy230
El Helou G, Lahr B, Razonable R. Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: is there a “Safe Corridor” after kidney transplantation? Transpl Infect Dis. 2021;23(2). doi:10.1111/tid.13489
Demey B, Tinez C, François C, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6-12. doi:10.1016/j.jcv.2018.10.002
Velioglu A, Aksu B, Asicioglu E, et al. Association of BK virus titers with lymphocyte count in renal transplant patients. Transplant Proc. 2015;47(5):1421-1424. doi:10.1016/j.transproceed.2015.04.042
Gras J, Le Flécher A, Dupont A, et al. Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case-control study. BMC Infect Dis. 2023;23(1):74. doi:10.1186/s12879-023-08043-z
Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation. 2002;73(8):1350-1353. doi:10.1097/00007890-200204270-00030
Dube GK, Batal I, Shah L, Robbins H, Arcasoy SM, Husain SA. BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation. Am J Transplant. 2023;23(2):284-290. doi:10.1016/j.ajt.2022.11.007
Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation. 2007;84(3):340-345. doi:10.1097/01.tp.0000275205.41078.51
Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol. 2004;42(3):1176-1180. doi:10.1128/JCM.42.3.1176-1180.2004
Pollara CP, Corbellini S, Chiappini S, et al. Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN. New Microbiol. 2011;34(2):165-171. http://www.ncbi.nlm.nih.gov/pubmed/21617828
Gruessner AC, Gruessner RWG. Pancreas transplantation of US and non-US cases from 2005 to 2014 as reported to the united network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR). Rev Diabet Stud. 2016;13(1):35-58. doi:10.1900/RDS.2016.13.35
Perry WA, Paulus JK, Price LL, Snydman DR, Chow JK. Association between lymphopenia at 1 month posttransplant and infectious outcomes or death in heart transplant recipients. Clin Infect Dis. 2021;73(11):e3797-e3803. doi:10.1093/cid/ciaa1800
Gardiner BJ, Nierenberg NE, Chow JK, Ruthazer R, Kent DM, Snydman DR. Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients. Clin Infect Dis. 2018;67(9):1395-1402. doi:10.1093/cid/ciy295
Schoeberl A-K, Zuckermann A, Kaider A, et al. Absolute lymphocyte count as a marker for cytomegalovirus infection after heart transplantation. Transplantation. 2023;107(3):748-752. doi:10.1097/TP.0000000000004360
Kandaswamy R, Stock PG, Miller J, et al. OPTN/SRTR 2020 annual data report: pancreas. Am J Transplant. 2022;22:137-203. doi:10.1111/ajt.16979